We are live on ! Find out more
LAB icon

Standard BioTools
LAB

131 hedge funds and large institutions have $854M invested in Standard BioTools in 2019 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 60 increasing their positions, 17 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

655% more call options, than puts

Call options by funds: $302K | Put options by funds: $40K

253% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 17

213% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 15

103% more capital invested

Capital invested by funds: $422M → $854M (+$433M)

32% more funds holding

Funds holding: 99 → 131 (+32)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

8.31% less ownership

Funds ownership: 101.5% → 93.19% (-8.3%)

Holders
131
Holders Change
+32
Holders Change %
+32.32%
% of All Funds
2.84%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
47
Increased
60
Reduced
17
Closed
15
Calls
$302K
Puts
$40K
Net Calls
+$262K
Net Calls Change
-$9K

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$19.2M
2
PHS
PFM Health Sciences
California
+$15.2M
3
RI
RTW Investments
New York
+$11M
4
Deutsche Bank
Deutsche Bank
Germany
+$10.8M
5
Renaissance Technologies
Renaissance Technologies
New York
+$9.64M

Top Sellers

1
LCS
Levin Capital Strategies
New York
-$98.9M
2
HVC
Healthcare Value Capital
New Jersey
-$3.88M
3
ICM
Indaba Capital Management
California
-$3.45M
4
PVI
Pura Vida Investments
New York
-$2.73M
5
Neuberger Berman Group
Neuberger Berman Group
New York
-$2.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
EIP
1
Easterly Investment Partners
Massachusetts
$124M +$98.3M +9,327,110 New
Primecap Management
2
Primecap Management
California
$87.5M -$944K -89,600 -1%
Russell Investments Group
3
Russell Investments Group
United Kingdom
$74.2M +$4.47M +423,877 +8%
Neuberger Berman Group
4
Neuberger Berman Group
New York
$69.3M -$2.64M -250,420 -5%
BlackRock
5
BlackRock
New York
$35.2M +$5.38M +510,396 +24%
DCM
6
Driehaus Capital Management
Illinois
$33.5M +$2.23M +211,831 +9%
Renaissance Technologies
7
Renaissance Technologies
New York
$28.6M +$9.64M +914,200 +74%
Vanguard Group
8
Vanguard Group
Pennsylvania
$27.1M +$2.53M +240,425 +13%
RI
9
RTW Investments
New York
$25.7M +$11M +1,046,699 +118%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$24.2M +$19.2M +1,820,000 New
PHS
11
PFM Health Sciences
California
$19.2M +$15.2M +1,441,363 New
Millennium Management
12
Millennium Management
New York
$16.4M +$3.18M +301,406 +32%
Deutsche Bank
13
Deutsche Bank
Germany
$15.9M +$10.8M +1,026,860 +593%
SSA
14
Schonfeld Strategic Advisors
New York
$15.3M +$2.08M +196,900 +21%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$12.4M +$7.51M +712,728 +323%
Citadel Advisors
16
Citadel Advisors
Florida
$12.2M +$9.12M +865,653 +1,715%
Two Sigma Investments
17
Two Sigma Investments
New York
$11.6M +$4.06M +384,880 +79%
Acadian Asset Management
18
Acadian Asset Management
Massachusetts
$11.2M +$3.24M +307,013 +57%
GIM
19
Granahan Investment Management
Massachusetts
$10.4M +$2.31M +219,426 +39%
Two Sigma Advisers
20
Two Sigma Advisers
New York
$10.3M +$4.3M +407,600 +111%
Canada Pension Plan Investment Board
21
Canada Pension Plan Investment Board
Ontario, Canada
$10.2M +$8.09M +767,114 New
Geode Capital Management
22
Geode Capital Management
Massachusetts
$8.49M +$1.97M +187,044 +41%
CAM
23
ClariVest Asset Management
California
$8.15M +$6.47M +613,514 New
State Street
24
State Street
Massachusetts
$7.65M +$81.5K +7,733 +1%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$7.29M +$946K +89,729 +20%
1
2 3 4 5

LAB Hedge Fund Activity: Q1 2019 in Review

131 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2019, worth a combined $854M — up 103% from $422M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new LAB positions and 15 closed out — a net gain of 32 holders — while 60 added to existing stakes and 17 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $19.2M. The largest seller was Levin Capital Strategies, cutting an estimated $98.9M.

  • 131 institutional investors held Standard BioTools (LAB) as of Q1 2019, up from 99 in Q4 2018.
  • Funds reported $854M of Standard BioTools stock for Q1 2019, up 103% quarter-over-quarter.
  • 47 funds opened new Standard BioTools positions in Q1 2019 and 15 closed out, a net change of +32 holders.
  • The largest Standard BioTools buyer in Q1 2019 was Fidelity Investments, an estimated $19.2M added.
  • The largest Standard BioTools seller in Q1 2019 was Levin Capital Strategies, an estimated $98.9M sold.

Based on aggregated 13F filings for Q1 2019.